Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

850 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials.
Lee MC, Hua YM, Yang CT, Kuo FH, Chang WT, Tang HJ, Siong Toh H, Lin YM, Chen SY, Chang HY, Liao CT. Lee MC, et al. Among authors: chang hy, chang wt. Medicine (Baltimore). 2022 Dec 23;101(51):e32489. doi: 10.1097/MD.0000000000032489. Medicine (Baltimore). 2022. PMID: 36595871 Free PMC article.
2023 Expert Consensus of the Taiwan Society of Cardiology on the Diagnosis and Treatment of Cardiac Amyloidosis.
Wang CC, Chang WT, Lin YH, Tzeng BH, Chao TH, Hung CL, Wu YW, Tsai CH, Lin WW, Chang KC, Chang HY, Yu WC, Wang WH, Cheng CI, Wang TD, Hou CJ, Chen WJ. Wang CC, et al. Among authors: chang hy, chang wt, chang kc. Acta Cardiol Sin. 2023 Jul;39(4):511-543. doi: 10.6515/ACS.202307_39(4).20230610A. Acta Cardiol Sin. 2023. PMID: 37456934 Free PMC article.
Real-World Analyses of the Treatment Conditions in Patients Initiating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor in Taiwan.
Lin PL, Wu YW, Lin CF, Yeh HI, Chang WT, Charng MJ, Huang PH, Lin CC, Lin TH, Lin WW, Hsieh IC, Kuo FY, Chen CP, Li YH. Lin PL, et al. Among authors: chang wt. J Atheroscler Thromb. 2023 Sep 1;30(9):1123-1131. doi: 10.5551/jat.63789. Epub 2022 Nov 24. J Atheroscler Thromb. 2023. PMID: 36418110 Free PMC article.
Sodium-Glucose Cotransporter 2 Inhibitors First Strategy Improve Decongestion in Patients with Symptomatic Heart Failure and Reduced Ejection Fraction When Compared to Angiotensin Receptor Neprilysin Inhibitor First Strategy.
Lee WC, Chang WT, Hong CS, Liao CT, Huang PS, Huang SC, Lin CH, Chiang CY, Chen ZC, Shih JY. Lee WC, et al. Among authors: chang wt. Front Biosci (Landmark Ed). 2023 Apr 27;28(4):81. doi: 10.31083/j.fbl2804081. Front Biosci (Landmark Ed). 2023. PMID: 37114551 Free article.
Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases.
Cheng PN, Chen WJ, Hou CJ, Lin CL, Chang ML, Wang CC, Chang WT, Wang CY, Lin CY, Hung CL, Peng CY, Yu ML, Chao TH, Huang JF, Huang YH, Chen CY, Chiang CE, Lin HC, Li YH, Lin TH, Kao JH, Wang TD, Liu PY, Wu YW, Liu CJ. Cheng PN, et al. Among authors: chang ml, chang wt. Clin Mol Hepatol. 2024 Jan;30(1):16-36. doi: 10.3350/cmh.2023.0315. Epub 2023 Oct 4. Clin Mol Hepatol. 2024. PMID: 37793641 Free PMC article. Review.
850 results